Harry J. Leonhardt

Insider Reports History

Entity
Individual
Location
C/O Halozyme Therapeutics, Inc., 11388 Sorrento Valley Blvd., San Diego, CA
Signature
/s/ Johanna Mylet, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Harry J. Leonhardt:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Poseida Therapeutics, Inc. GC & Chief Compliance Officer Common Stock 0 $0 $9.60 Jan 8, 2025 Direct
Poseida Therapeutics, Inc. GC & Chief Compliance Officer Employee Stock Option (Right to Buy) 112K Mar 1, 2024 Direct
Poseida Therapeutics, Inc. GC & Chief Compliance Officer Employee Stock Option (Right to Buy) 0 Jan 8, 2025 Direct

Insider Reports Filed by Harry J. Leonhardt

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PSTX Poseida Therapeutics, Inc. Jan 8, 2025 6 $0 4 Jan 8, 2025 GC & Chief Compliance Officer
PSTX Poseida Therapeutics, Inc. Mar 1, 2024 3 -$67.3K 4 Mar 4, 2024 GC & Chief Compliance Officer
PSTX Poseida Therapeutics, Inc. Mar 1, 2023 3 -$23.1K 4 Mar 2, 2023 GC & Chief Compliance Officer
PSTX Poseida Therapeutics, Inc. Mar 1, 2022 2 $0 4 Mar 1, 2022 GC & Chief Compliance Officer